Skip to content
MedsAcross

Medicine

Verapamil 40 mg tablet

Verapamil · Oral
Available on requestPrescription onlyUS FDAGeneric name

Verapamil 40 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Verapamil
Brand
Sold under the generic name
Strength
40 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 90 tablets, 30 tablets and 3 more
Manufacturers
Avet PharmaceuticalsIndiaActavis PharmaAvKAREBryant Ranch PrepackChartwell RXGolden State Medical Supply
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C08DA01 Verapamil
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 June 1993
Identifiers
RxCUI 897722, 897666, 897683DailyMed set ID 2f232216-db62-4dc6-a5a7-9139d7ac7589, a32f346e-71cf-cc11-e053-2a95a90ae88c, 3283bba6-05dd-3766-e063-6394a90ada69 +3NDC 71335-2087, 42291-853, 51407-962 +3Application ANDA072924, ANDA071881

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle23155-059-01Avet PharmaceuticalsIndia15 October 2015
100 tablet, film coated in 1 bottle, plastic0591-0404-01Actavis Pharma29 June 1993
90 tablet in 1 bottle62135-743-90Chartwell RX8 August 2023
100 tablet in 1 bottle42291-853-01AvKARE13 April 2020
30 tablet, film coated in 1 bottle, plastic71335-2087-1Bryant Ranch Prepack16 May 2022
100 tablet in 1 bottle51407-962-01Golden State Medical Supply5 March 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 August 1981Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Verapamil

Clinical summary

Verapamil is a calcium channel blocker indicated for the treatment of supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). MedsAcross supplies Verapamil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Verapamil

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Verapamil 40 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.